Tower Research Capital LLC (Trc) Scopus Bio Pharma Inc. Transaction History

Tower Research Capital LLC (Trc)

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	SELL	$0.23 - $0.45 $373 - $731	-1,625 Reduced 5.77%	26,533 $6,000
Q2 2022 Aug 15, 2022	BUY	$0.36 - $0.74 $6,829 - $14,038	18,971 Added 206.5%	28,158 $12,000
Q1 2022 May 12, 2022	BUY	$0.6 - $1.7 $2,070 - $5,865	3,450 Added 60.14%	9,187 $6,000
Q4 2021 Feb 14, 2022	SELL	$1.63 - $4.28 $27,679 - $72,678	-16,981 Reduced 74.75%	5,737 $9,000
Q3 2021 Nov 15, 2021	BUY	$4.0 - $6.99 $79,532 - $138,982	19,883 Added 701.34%	22,718 $94,000
Q2 2021 Aug 16, 2021	BUY	$5.17 - $10.25 $13,638 - $27,039	2,638 Added 1339.09%	2,835 $20,000
Q1 2021 May 17, 2021	SELL	$7.94 - $14.87 $9,313 - $17,442	-1,173 Reduced 85.62%	197 $2,000
Q4 2020 Feb 16, 2021	BUY	$5.92 - $33.96 $8,110 - $46,525	1,370 New	1,370 $20,000

100

Ticker SCPS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 21,094,300
Description
Scopus BioPharma Inc., a clinical-stage biopharmaceutical company, focuses on developing transformational therapeutics targeting serious diseases. The company lead development programs are immuno-oncology gene therapy for the treatment of various cancers. It offers Duet Platform, a CpG signal transducer and activator of transcription 3 (STAT3) i...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.